ArticleJournal of neuromuscular diseases2026
Orofacial dysfunction in persons with congenital or childhood-onset neuromuscular disorders.
Article in Journal of neuromuscular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundSome symptoms of orofacial dysfunction, such as dysphagia and dysarthria, are commonly encountered in congenital or childhood-onset neuromuscular diseases (NMD), while others, such as reduced saliva control and difficulties using facial expressions, are not as well researched. Overall, there is a lack of knowledge regarding the extents to which different orofacial functions are affected in persons with NMD.ObjectiveTo identify orofacial dysfunction profiles at group level for congenital or childhood-onset NMD.MethodsThis database study included 206 individuals in the age range of 3-48 years with 21 different congenital or childhood-onset NMD, categorized as anterior horn cell diseases, neuropathies and myopathies. Orofacial dysfunction profiles from the Nordic Orofacial Test - Screening were extracted from a national database of oral health and orofacial functions in rare health conditions.ResultsIn the study population, 70% presented with signs of orofacial dysfunction. Neuropathies had the lowest rate of orofacial dysfunctions (25%), followed by myopathies (72%). Anterior horn cell diseases had the highest rate of orofacial dysfunctions (82%). In all the groups, there were individuals without orofacial dysfunction, except for the subgroups of Spinal Muscular Atrophy type 1 and Duchenne Muscular Dystrophy with age range of 19-49 years in which all the participants (100%) demonstrated orofacial dysfunction according to NOT-S.ConclusionsThis study identifies a considerable proportion of individuals with congenital and childhood-onset NMD exhibiting signs of orofacial dysfunction, indicating the need for further investigation. It also shows to what extents different orofacial functions are affected in subgroups of NMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.